Securities code: Tellgen Corporation(300642) securities abbreviation: Tellgen Corporation(300642) Announcement No.: 2022030 Tellgen Corporation(300642)
First quarter report 2022
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. Important content tips: 1. The board of directors, the board of supervisors, directors, supervisors and senior managers guarantee that the quarterly report is true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities. 2. The person in charge of the company, the person in charge of accounting and the person in charge of the accounting organization (Accounting Supervisor) declare that they guarantee the authenticity, accuracy and completeness of the financial information in the quarterly report. 3. Whether the first quarter report has been audited □ yes √ No 1. Main financial data (I) whether the company needs to retroactively adjust or restate the accounting data of previous years □ yes √ no
Increase or decrease in the reporting period compared with the same period of the previous year
Operating income (yuan): 1450997664011864488485 22.30%
Net profit attributable to shareholders of the listed company (yuan) 5270134332 Shenzhen Bioeasy Biotechnology Co.Ltd(300942) 695 – 77.10%
Net profit attributable to shareholders of listed companies after deducting non recurring profits and losses of 3065114092114806754 – 85.51% (yuan)
Net cash flow from operating activities (yuan): 6967038841 -3247967099 314.50%
Basic earnings per share (yuan / share) 0.032 0.141 – 77.30%
Diluted earnings per share (yuan / share) 0.032 0.141 – 77.30%
Weighted average return on net assets: 0.38%, 1.03% – 0.65%
Increase or decrease at the end of the reporting period compared with the end of the previous year
Total assets (yuan): 152325871668149884220860 1.63%
Owner’s equity attributable to shareholders of listed companies 139425933582139383062264 0.03% (yuan) (II) non recurring profit and loss items and amount √ applicable □ not applicable
Unit: Yuan
Description of the amount of the project in the current reporting period
Government subsidies included in current profits and losses (closely related to the company’s normal business, in line with national 64038641)
Except for the government subsidies that are continuously enjoyed according to certain standard quota or quota according to the national policy, except for the effective hedging business related to the normal business of the company, the trading fund shall be held
Profit and loss from changes in fair value arising from financial assets and trading financial liabilities, and disposal of transactions 200456124
Investment income from financial assets held for trading, financial liabilities held for trading and financial assets available for sale
Other non operating income and expenditure other than the above -5080619
Less: income tax impact 38912122
Total 220502024–
Details of other profit and loss items that meet the definition of non recurring profit and loss: □ applicable √ not applicable. The company does not have details of other profit and loss items that meet the definition of non recurring profit and loss. Description of defining the non recurring profit and loss items listed in the explanatory announcement on information disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items □ applicable √ not applicable the company does not define the non recurring profit and loss items listed in the explanatory announcement on Information Disclosure of companies offering securities to the public No. 1 – non recurring profit and loss as recurring profit and loss items.
（3） Changes and reasons of main accounting data and financial indicators √ applicable □ not applicable
Unit: Yuan
Balance sheet items March 31, 2022 and December 31, 2021 reasons for changes in the ratio at the end of the reporting period
Increase or decrease at the end of last year
Monetary capital 3071624329218621200257 64.95% was mainly due to the increase in the recovery of purchase financial management funds in the reporting period compared with the same period in history
Prepayment 1028118454782093272 31.46% was mainly due to the increase of prepayment in the reporting period compared with the same period in history
Accounts payable 59028601034176764414 41.33% was mainly due to the increase of purchase in the credit period in the reporting period compared with the same period in history
The contract liabilities were 22515210721177650114 91.19%, which was mainly due to the increase of prepayments received from corresponding sales contracts in the reporting period compared with the same period in history
Payroll payable 27819180 – mainly due to the increase of payroll payable but unpaid in the reporting period compared with the same period in history
The tax payable was 187172631664242650 – 71.82%, mainly due to the decrease of unpaid tax payable in the reporting period compared with the same period in history
Other current liabilities 284015207151728736 87.19% were mainly due to the increase of tax to be written off in the reporting period compared with the same period in history
Treasury stock 2518876 Lotus Health Group Company(600186) 7496773 34.88% was mainly due to the company’s share repurchase in the secondary market during the reporting period
Unit: Yuan
Amount of income statement items in the current period and reasons for changes in amount in the previous period
This is mainly due to the increase of operating costs caused by the increase of sales operating costs of 71603875563704159599 and 93.31% revenue in the reporting period compared with the same period in history, and the proportion of agency products increased more
This is mainly due to the increase of sales tax and surcharges of 243979616, 44888725 and 443.52% in this reporting period compared with the same period in history, as well as the increase of taxes and surcharges caused by the new real estate tax
This is mainly due to the decrease of financial management expenses of – 26408240 – 50354359 – 47.56% in the reporting period compared with the same period in history, and the increase of relevant interest expenses recognized in the new leasing standards
Other income
